@article{2277,
  keywords = {Anti-Inflammatory Agents, Non-Steroidal, Biopsy, Bone Marrow Transplantation, Child, Clofazimine, Duodenal Diseases, Duodenum, Endoscopy, Gastrointestinal, Graft vs Host Disease, Humans, Ileal Diseases, Male},
  author = {Parizhskaya M and Youssef N N and Di Lorenzo C and Goyal R K},
  title = {Clofazimine enteropathy in a pediatric bone marrow transplant recipient.},
  abstract = {<p>Clofazimine, previously used in the treatment of leprosy, is now used for treatment of Mycobacterium avium complex infection in patients with acquired immune deficiency syndrome, dermatologic disorders, and graft-versus-host disease. An 11-year-old boy developed a severe enteropathy 2 years after initiation of clofazimine treatment for graft-versus-host disease. Clofazimine enteropathy caused by crystal deposition can be life-threatening.</p>},
  year = {2001},
  journal = {The Journal of pediatrics},
  volume = {138},
  pages = {574-6},
  month = {2001 Apr},
  issn = {0022-3476},
  doi = {10.1067/mpd.2001.111327},
  language = {eng},
}